Models are for illustrative purposes only.
TARKA combines a slow-release calcium channel blocker and an immediate-release angiotensin converting enzyme (ACE) inhibitor to help control blood pressure numbers.1
This is the most important information you should know about TARKA. For more information, talk to your doctor.
Reference: 1. TARKA [package insert]. North Chicago, IL: AbbVie Inc.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call
If you cannot afford your medication, contact www.pparx.org for assistance.
If you have any questions about AbbVie's MyTARKA.com website that have not been answered, click here. This website and the information contained herein is intended for use by US residents only, is provided for informational purposes only, and is not intended to replace a discussion with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider and take into consideration the unique characteristics of each patient.